ReviewCancers2025

Repurposing the Tyrosine Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Cancer Therapy: A Comprehensive Review.

Sergei Boichuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.